P3 Health Partners (PIII) Stock Price, News & Analysis

Company Overview

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Key Stats

• Today's Range: $0.50 to $0.51
• 50-Day Range: $0.46 to $0.63
• 52-Week Range: $0.40 to $2.21
• Volume: 66,458 shs
• Average Volume: 372,452 shs
• Market Capitalization: $158.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.50
• Consensus Rating: Moderate Buy

P3 Health Partners Stock Analysis - MarketRank™

P3 Health Partners scored higher than 56% of companies evaluated by MarketBeat, and ranked 562nd out of 995 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

P3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

P3 Health Partners has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for P3 Health Partners are expected to decrease in the coming year, from ($0.23) to ($0.25) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of P3 Health Partners is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of P3 Health Partners is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

P3 Health Partners has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.42% of the float of P3 Health Partners has been sold short.

Short Interest Ratio / Days to Cover

P3 Health Partners has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in P3 Health Partners has recently increased by 0.81%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

P3 Health Partners does not currently pay a dividend.

Dividend Growth

P3 Health Partners does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.42% of the float of P3 Health Partners has been sold short.

Short Interest Ratio / Days to Cover

P3 Health Partners has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in P3 Health Partners has recently increased by 0.81%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 1.02

News Sentiment

P3 Health Partners has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for P3 Health Partners this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, P3 Health Partners insiders have bought more of their company's stock than they have sold. Specifically, they have bought $205,600.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

17.86% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 7.75% of the stock of P3 Health Partners is held by institutions.

PIII Stock Analysis - Frequently Asked Questions

How have PIII shares performed this year?

P3 Health Partners' stock was trading at $1.41 on January 1st, 2024. Since then, PIII stock has decreased by 64.5% and is now trading at $0.5002.
View the best growth stocks for 2024 here.

How were P3 Health Partners' earnings last quarter?

P3 Health Partners Inc. (NASDAQ:PIII) released its earnings results on Wednesday, August, 7th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.07. The company had revenue of $379.16 million for the quarter, compared to analyst estimates of $364.50 million. P3 Health Partners had a negative trailing twelve-month return on equity of 43.19% and a negative net margin of 4.95%.

Who are P3 Health Partners' major shareholders?

P3 Health Partners' top institutional investors include Armistice Capital LLC (2.50%), Emfo LLC (0.45%), Sanders Morris Harris LLC (0.05%) and Renaissance Technologies LLC (0.04%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou, Atul Kavthekar and Michael Balkin.
View institutional ownership trends.

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/07/2024
• Today: 9/17/2024
• Next Earnings (Estimated): 11/13/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:PIII
• CUSIP: N/A
• CIK: 1832511
• Web: foresightacq.com
• Phone: 702-910-3950
• Fax: N/A
• Employees: 500
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $4.50
• High Stock Price Target: $4.50
• Low Stock Price Target: $4.50
• Potential Upside/Downside: +799.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.59)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-57,770,000.00
• Net Margins: -4.95%
• Pretax Margin: -12.80%
• Return on Equity: -43.19%
• Return on Assets: -7.93%

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 0.69
• Quick Ratio: 0.69

Sales & Book Value

• Annual Sales: $1.40 billion
• Price / Sales: 0.11
• Cash Flow: $0.09 per share
• Price / Cash Flow: 5.79
• Book Value: $0.45 per share
• Price / Book: 1.11

Miscellaneous

• Outstanding Shares: 316,115,000
• Free Float: 259,657,000
• Market Cap: $158.12 million
• Optionable: Not Optionable
• Beta: 1.17